Annual FCF
-$6.14 M
+$12.37 M+66.84%
31 December 2023
Summary:
Galmed Pharmaceuticals annual free cash flow is currently -$6.14 million, with the most recent change of +$12.37 million (+66.84%) on 31 December 2023. During the last 3 years, it has risen by +$20.19 million (+76.69%). GLMD annual FCF is now -141.90% below its all-time high of -$2.54 million, reached on 31 December 2013.GLMD Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$1.06 M
-$47.00 K-4.62%
30 September 2024
Summary:
Galmed Pharmaceuticals quarterly free cash flow is currently -$1.06 million, with the most recent change of -$47.00 thousand (-4.62%) on 30 September 2024. Over the past year, it has increased by +$1.11 million (+51.13%). GLMD quarterly FCF is now -537.13% below its all-time high of -$167.00 thousand, reached on 30 June 2013.GLMD Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$4.81 M
+$1.11 M+18.79%
30 September 2024
Summary:
Galmed Pharmaceuticals TTM free cash flow is currently -$4.81 million, with the most recent change of +$1.11 million (+18.79%) on 30 September 2024. Over the past year, it has increased by +$4.46 million (+48.09%). GLMD TTM FCF is now -954.61% below its all-time high of -$456.00 thousand, reached on 31 March 2013.GLMD TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GLMD Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +66.8% | +51.1% | +48.1% |
3 y3 years | +76.7% | +88.2% | +85.8% |
5 y5 years | +32.7% | +72.5% | +63.5% |
GLMD Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +81.3% | -18.5% | +88.2% | at high | +85.8% |
5 y | 5 years | at high | +81.3% | -18.5% | +88.5% | at high | +85.8% |
alltime | all time | -141.9% | +81.3% | -537.1% | +88.5% | -954.6% | +85.8% |
Galmed Pharmaceuticals Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$1.06 M(+4.6%) | -$4.81 M(-18.8%) |
June 2024 | - | -$1.02 M(-44.4%) | -$5.92 M(-5.6%) |
Mar 2024 | - | -$1.83 M(+103.8%) | -$6.27 M(+2.2%) |
Dec 2023 | -$6.14 M(-66.8%) | -$898.00 K(-58.8%) | -$6.14 M(-33.8%) |
Sept 2023 | - | -$2.18 M(+59.3%) | -$9.26 M(-9.2%) |
June 2023 | - | -$1.37 M(-19.4%) | -$10.20 M(-30.8%) |
Mar 2023 | - | -$1.70 M(-57.9%) | -$14.75 M(-20.3%) |
Dec 2022 | -$18.50 M(-43.8%) | -$4.03 M(+29.3%) | -$18.50 M(-13.8%) |
Sept 2022 | - | -$3.11 M(-47.3%) | -$21.47 M(-21.5%) |
June 2022 | - | -$5.91 M(+8.5%) | -$27.34 M(-5.9%) |
Mar 2022 | - | -$5.45 M(-22.0%) | -$29.07 M(-11.7%) |
Dec 2021 | -$32.90 M(+25.0%) | -$6.99 M(-22.2%) | -$32.90 M(-2.5%) |
Sept 2021 | - | -$8.99 M(+17.7%) | -$33.76 M(+11.0%) |
June 2021 | - | -$7.64 M(-17.8%) | -$30.41 M(+4.8%) |
Mar 2021 | - | -$9.29 M(+18.3%) | -$29.03 M(+10.3%) |
Dec 2020 | -$26.33 M(+76.1%) | -$7.85 M(+39.3%) | -$26.33 M(+16.8%) |
Sept 2020 | - | -$5.63 M(-10.0%) | -$22.55 M(+8.5%) |
June 2020 | - | -$6.26 M(-5.0%) | -$20.79 M(+17.4%) |
Mar 2020 | - | -$6.59 M(+61.9%) | -$17.71 M(+18.5%) |
Dec 2019 | -$14.95 M(+64.0%) | -$4.07 M(+5.1%) | -$14.95 M(+13.5%) |
Sept 2019 | - | -$3.87 M(+21.7%) | -$13.17 M(+17.5%) |
June 2019 | - | -$3.18 M(-16.8%) | -$11.21 M(+18.3%) |
Mar 2019 | - | -$3.83 M(+67.2%) | -$9.47 M(+3.9%) |
Dec 2018 | -$9.11 M | -$2.29 M(+19.6%) | -$9.11 M(-2.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2018 | - | -$1.91 M(+32.2%) | -$9.31 M(-9.5%) |
June 2018 | - | -$1.45 M(-58.3%) | -$10.29 M(-11.7%) |
Mar 2018 | - | -$3.47 M(+39.4%) | -$11.66 M(-3.4%) |
Dec 2017 | -$12.08 M(-0.6%) | -$2.49 M(-14.2%) | -$12.08 M(-2.7%) |
Sept 2017 | - | -$2.90 M(+2.8%) | -$12.41 M(-2.5%) |
June 2017 | - | -$2.82 M(-27.4%) | -$12.73 M(-1.6%) |
Mar 2017 | - | -$3.88 M(+37.9%) | -$12.94 M(+6.5%) |
Dec 2016 | -$12.15 M(+40.7%) | -$2.81 M(-12.4%) | -$12.15 M(+5.1%) |
Sept 2016 | - | -$3.21 M(+6.2%) | -$11.56 M(+8.9%) |
June 2016 | - | -$3.03 M(-1.9%) | -$10.61 M(+12.1%) |
Mar 2016 | - | -$3.09 M(+38.7%) | -$9.46 M(+9.6%) |
Dec 2015 | -$8.63 M(-13.8%) | -$2.23 M(-1.8%) | -$8.63 M(-11.6%) |
Sept 2015 | - | -$2.27 M(+20.6%) | -$9.77 M(+2.2%) |
June 2015 | - | -$1.88 M(-16.7%) | -$9.55 M(-4.9%) |
Mar 2015 | - | -$2.26 M(-32.8%) | -$10.04 M(+0.3%) |
Dec 2014 | -$10.01 M(+294.6%) | -$3.36 M(+63.3%) | -$10.01 M(+32.2%) |
Sept 2014 | - | -$2.06 M(-13.2%) | -$7.57 M(+16.4%) |
June 2014 | - | -$2.37 M(+6.6%) | -$6.51 M(+51.2%) |
Mar 2014 | - | -$2.22 M(+141.2%) | -$4.30 M(+69.7%) |
Dec 2013 | -$2.54 M(-18.5%) | -$922.00 K(-7.1%) | -$2.54 M(+57.1%) |
Sept 2013 | - | -$992.00 K(+494.0%) | -$1.61 M(+159.2%) |
June 2013 | - | -$167.00 K(-63.4%) | -$623.00 K(+36.6%) |
Mar 2013 | - | -$456.00 K | -$456.00 K |
Dec 2012 | -$3.11 M | - | - |
FAQ
- What is Galmed Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals annual FCF year-on-year change?
- What is Galmed Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals quarterly FCF year-on-year change?
- What is Galmed Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Galmed Pharmaceuticals?
- What is Galmed Pharmaceuticals TTM FCF year-on-year change?
What is Galmed Pharmaceuticals annual free cash flow?
The current annual FCF of GLMD is -$6.14 M
What is the all time high annual FCF for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high annual free cash flow is -$2.54 M
What is Galmed Pharmaceuticals annual FCF year-on-year change?
Over the past year, GLMD annual free cash flow has changed by +$12.37 M (+66.84%)
What is Galmed Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of GLMD is -$1.06 M
What is the all time high quarterly FCF for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high quarterly free cash flow is -$167.00 K
What is Galmed Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, GLMD quarterly free cash flow has changed by +$1.11 M (+51.13%)
What is Galmed Pharmaceuticals TTM free cash flow?
The current TTM FCF of GLMD is -$4.81 M
What is the all time high TTM FCF for Galmed Pharmaceuticals?
Galmed Pharmaceuticals all-time high TTM free cash flow is -$456.00 K
What is Galmed Pharmaceuticals TTM FCF year-on-year change?
Over the past year, GLMD TTM free cash flow has changed by +$4.46 M (+48.09%)